IL-13 Receptor Isoforms: Breaking Through the Complexity

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2007 Aug 19

PMID 17697639

Citations 39

Authors

Yasuhiro Tabata

Gurjit K Khurana Hershey

Affiliations

Soon will be listed here.

Abstract

Interleukin (IL)-13 is an immunoregulatory cytokine secreted predominantly by activated T-helper type 2 (Th2) cells, and it has been identified as crucial in developing allergic inflammatory responses. Its diverse functions are mediated by a complex receptor system including IL-4 receptor alpha (IL-4Ralpha; CD124) and two other cognate cell surface proteins, IL-13Ralpha1 (CD213a1) and IL-13Ralpha2 (CD213a2). IL-13Ralpha1 forms a heterodimer with IL-4Ralpha that is a signaling IL-13 receptor. In contrast, IL-13Ralpha2 has been thought to be a decoy receptor due to its short cytoplasmic tail. IL-13Ralpha2 exists on the cell membrane, intracellularly, and in soluble form. Recent reports revealed that membrane IL-13Ralpha2 may have some signaling capabilities, and soluble IL-13Ralpha2 is a critical endogenous modulator for IL-13 responses. The receptor has more complicated functions than a simple decoy receptor. In this review, we describe the isoforms of IL-13Ralpha2 and discuss newly revealed functions of IL-13Ralpha2.

Citing Articles

Association of interleukin-4, interleukin-13 gene polymorphisms, HLA-DQ and DR genotypes with genetic susceptibility of type-1 Diabetes Mellitus in Kuwaiti children.

Haider M, Al Rushood M, Alsharhan H, Rasoul M, Al-Mahdi M, Al-Kandari H Front Pediatr. 2023; 11:1118137.

PMID: 37090926 PMC: 10117788. DOI: 10.3389/fped.2023.1118137.

DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme.

Bhojnagarwala P, OConnell R, Park D, Liaw K, Ali A, Bordoloi D Mol Ther Oncolytics. 2022; 26:289-301.

PMID: 36090479 PMC: 9418050. DOI: 10.1016/j.omto.2022.07.003.

The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells.

Sobolev V, Tchepourina E, Korsunskaya I, Geppe N, Chebysheva S, Soboleva A Int J Mol Sci. 2022; 23(17).

PMID: 36077103 PMC: 9456565. DOI: 10.3390/ijms23179708.

A Novel Role of IL13Rα2 in the Pathogenesis of Proliferative Vitreoretinopathy.

Qi H, Dong L, Fang D, Chen L, Wang Y, Fan N Front Med (Lausanne). 2022; 9:831436.

PMID: 35770008 PMC: 9234175. DOI: 10.3389/fmed.2022.831436.

HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma.

Tseng C, Huang S, Tsai H, Wu C, Hsieh T Sci Rep. 2022; 12(1):10513.

PMID: 35732647 PMC: 9217956. DOI: 10.1038/s41598-022-14052-w.

References

Guo J, Apiou F, Mellerin M, Lebeau B, Jacques Y, Minvielle S . Chromosome mapping and expression of the human interleukin-13 receptor. Genomics. 1997; 42(1):141-5. DOI: 10.1006/geno.1997.4628. View

Andrews R, ROSA L, Daines M, Khurana Hershey G . Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity. J Immunol. 2001; 166(3):1716-22. DOI: 10.4049/jimmunol.166.3.1716. View

Daines M, Tabata Y, Walker B, Chen W, Warrier M, Basu S . Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J Immunol. 2006; 176(12):7495-501. DOI: 10.4049/jimmunol.176.12.7495. View

Daines M, Khurana Hershey G . A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J Biol Chem. 2002; 277(12):10387-93. DOI: 10.1074/jbc.M108109200. View

Chiaramonte M, Mentink-Kane M, Jacobson B, Cheever A, Whitters M, Goad M . Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med. 2003; 197(6):687-701. PMC: 2193852. DOI: 10.1084/jem.20020903. View

Granel B, Allanore Y, Chevillard C, Arnaud V, Marquet S, Weiller P . IL13RA2 gene polymorphisms are associated with systemic sclerosis. J Rheumatol. 2006; 33(10):2015-9. View

Tabata Y, Chen W, Warrier M, Gibson A, Daines M, Khurana Hershey G . Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms. J Immunol. 2006; 177(11):7905-12. DOI: 10.4049/jimmunol.177.11.7905. View

Kawakami K, Terabe M, Kawakami M, Berzofsky J, Puri R . Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain. Cancer Res. 2006; 66(8):4434-42. DOI: 10.1158/0008-5472.CAN-05-1265. View

Akaiwa M, Yu B, Terada N, Suto H, Koga T, Arima K . Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine. 2001; 13(2):75-84. DOI: 10.1006/cyto.2000.0814. View

10.

Caput D, Laurent P, Kaghad M, Lelias J, Lefort S, Vita N . Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem. 1996; 271(28):16921-6. DOI: 10.1074/jbc.271.28.16921. View

11.

Daines M, Chen W, Tabata Y, Walker B, Gibson A, Masino J . Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy. J Allergy Clin Immunol. 2006; 119(2):375-83. PMC: 5472628. DOI: 10.1016/j.jaci.2006.09.039. View

12.

Wills-Karp M . Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep. 2004; 4(2):123-31. DOI: 10.1007/s11882-004-0057-6. View

13.

Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E . Characterization of the interaction between interleukin-13 and interleukin-13 receptors. J Biol Chem. 2005; 280(26):24915-22. DOI: 10.1074/jbc.M502571200. View

14.

Rahaman S, Vogelbaum M, Haque S . Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2. Cancer Res. 2005; 65(7):2956-63. DOI: 10.1158/0008-5472.CAN-04-3592. View

15.

Donaldson D, Whitters M, Fitz L, Neben T, Finnerty H, Henderson S . The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol. 1998; 161(5):2317-24. View

16.

Andrews A, Holloway J, Puddicombe S, Holgate S, Davies D . Kinetic analysis of the interleukin-13 receptor complex. J Biol Chem. 2002; 277(48):46073-8. DOI: 10.1074/jbc.M209560200. View

17.

Kioi M, Seetharam S, Puri R . N-linked glycosylation of IL-13R alpha2 is essential for optimal IL-13 inhibitory activity. FASEB J. 2006; 20(13):2378-80. DOI: 10.1096/fj.06-5995fje. View

18.

Zhang J, Hilton D, Willson T, McFarlane C, Roberts B, Moritz R . Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J Biol Chem. 1997; 272(14):9474-80. DOI: 10.1074/jbc.272.14.9474. View

19.

Levine S . Mechanisms of soluble cytokine receptor generation. J Immunol. 2004; 173(9):5343-8. DOI: 10.4049/jimmunol.173.9.5343. View

20.

Murata T, Husain S, Mohri H, Puri R . Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. Int Immunol. 1998; 10(8):1103-10. DOI: 10.1093/intimm/10.8.1103. View